As shown in Figure 2A, FCGR3A is significantly positively correlated with FGL2 expression in all tumor types (R=0.43), while the correlation between FCGR3A and FGL2 is more prominent in glioma samples (R=0.79). This evidence concerns the gene FCGR3A and central nervous system cancer.